The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
TFF2+ GASTRIC CORPUS PROGENITORS DIRECTLY CONTRIBUTE TO THE DEVELOPMENT OF METAPLASIA/SPEM
EPITHELIAL-DERIVED NADPH OXIDASE (NOX)-1 IN ENTERAL GLUCOSE-MEDIATED RESTORATION OF CRYPT ACTIVITY AND REINFORCEMENT OF BARRIER FUNCTION IN ISCHEMIC JEJUNUM
DUAL ACTIVATION OF GCGR/GLP1R SIGNALING AMELIORATES INTESTINAL FIBROSIS VIA METABOLIC REGULATION OF HISTONE H3K9 LACTYLATION IN EPITHELIAL CELLS
BRD4 AS A POTENTIAL THERAPEUTIC TARGET FOR CROHN’S DISEASE-ASSOCIATED FIBROSIS
CHARACTERIZATION OF PATIENT-DERIVED INTESTINAL ORGANOIDS FOR MODELING FIBROSIS IN INFLAMMATORY BOWEL DISEASE
INTER-ORGAN TRANSCRIPTOME HETEROGENEITY OF FIBROBLASTS IN THE GASTROINTESTINAL TRACT REVEALS POTENTIAL MECHANISMS UNDERLYING OESOPHAGEAL STRICTURE.
Through the history of gut microbiome research, basic, translational, and clinical studies revealed many critical roles played by gut-resident bacteria in affecting human health and disease…
SOCIETY: AGA This session will explore the complex dynamics between the gut microbiome and immune checkpoint inhibitors, addressing whether specific microbes/metabolites enhance therapeutic outcomes acting as allies or present challenges as potential foes, impacting treatment efficacy and associate…